Skip to main content

Brainclinics News

The latest news about Brainclinis

On June 12th 2026 the BCNBP - Belgian College of Neuropsychopharmacology & Biological Psychiatry organises an inspiring day focuse...

13 March 2026
On June 12th 2026 the BCNBP - Belgian College of Neuropsychopharmacology & Biological Psychiatry organises an inspiring day focused around rTMS, titled "Let's get wired - how do we bring rTMS into clinical practice". Speakers include: Sophie Fitzsimmons on rTMS' working mechanisms Chris Baeken on clinical perspectives on rTMS Iris Dalhuisen on maintenance treatment with rTMS Martijn Arns on the organization and history of rTMS in the Netherlands The full program and link for registration can be found on the website: https://lnkd.in/ev6JUhJv

Looking forward presenting tomorrow, will bridge the gap between biofeedback and TMS-induced Heart-Brain Coupling. See you there!...

10 March 2026
Looking forward presenting tomorrow, will bridge the gap between biofeedback and TMS-induced Heart-Brain Coupling. See you there! https://lnkd.in/eu64hXvB

Impressive results from AtaiBeckley re BPL-003 (5-MeO-DMT) in TRD: 76% remission after just 2 doses (8mg+12mg) after 2 mo. in Ph2B...

06 March 2026
Impressive results from AtaiBeckley re BPL-003 (5-MeO-DMT) in TRD: 76% remission after just 2 doses (8mg+12mg) after 2 mo. in Ph2B. Higher remission than other interventional psychiatry tx such as accelerated TMS, quicker (and lasting) remission and requiring less time. Use of 8mg+8mg in prospective Ph3 study (instead of 8+12mg) at odds with data (see figure). Use of 4mg as a control also sounds risky, might lack 'dose-response' effects. #5-MeO-DMT #Psychedelics

Just out: New Consensus Statement: Maintenance rTMS for Depression (Netherlands & Belgium). Congrats Iris Dalhuisen for leading th...

02 March 2026
Just out: New Consensus Statement: Maintenance rTMS for Depression (Netherlands & Belgium). Congrats Iris Dalhuisen for leading this effort. 📄 Full article: https://lnkd.in/eR2GfZKZ Acute rTMS is now firmly embedded in treatment guidelines for depression. But what about after response? In the newly published consensus statement in Transcranial Magnetic Stimulation, we systematically reviewed 22 studies and combined this with expert panel discussions and real-world survey data from Dutch and Belgian centers. Key insights: • Clear differentiation between tapering, maintenance rTMS, and retreatment • Tapering may reduce early relapse risk • Monthly clustered protocols (5 sessions over 2–5 days) show the most consistent signal of benefit • Single-session maintenance shows mixed evidence • Retreatment is effective in the majority of prior responders, often requiring fewer sessions • Strong emphasis on patient monitoring and shared decision-making Importantly, evidence remains limited and largely uncontrolled, underscoring the need for properly powered RCTs comparing maintenance strategies. This paper aims to bring structure to a field where clinical practice has outpaced the evidence. If you are working with rTMS and struggling with the “what next after remission?” question, this may be relevant to your practice.

Congrats Neumarker Inc. team with the lead for TDBRAIN diagnostic status prediction! Also... an invitation to all 'AI/ML' speciali...

24 February 2026
Congrats Neumarker Inc. team with the lead for TDBRAIN diagnostic status prediction! Also... an invitation to all 'AI/ML' specialists, if you can do magic with information rich brain time-series data such as EEG, have a crack at the data! See here for more information: https://lnkd.in/eseDiM9p

Great to see this out! Congrats Lena Kozyr and Stanford Brain Stimulation Lab!

20 February 2026
Great to see this out! Congrats Lena Kozyr and Stanford Brain Stimulation Lab!

Fostering robustness and reproducibility in applied neuroscience and AI/ML!

03 February 2026
Fostering robustness and reproducibility in applied neuroscience and AI/ML!

Just came back from Palestine and really enjoyed training the UEF teams from Betlehem and Nablus on the use of TMS in mental healt...

18 December 2025
Just came back from Palestine and really enjoyed training the UEF teams from Betlehem and Nablus on the use of TMS in mental health. We also donated two TMS systems for use in Bethlehem and Nablus, which makes it the first TMS available in Palestine! Big thanks also to Alexander Sack for donating a TMS machine and Trevor Brown, Klaus Schellhorn, DEYMED Diagnostic and others for support. The initiative was made possible in collaboration with Dr Asad, Daniel Kropf and Education for Life.

Kirby Wraith's method became #1 (by a margin) on the main leader board in benchmarking EEG-analysis algorithms to predict depressi...

04 December 2025
Kirby Wraith's method became #1 (by a margin) on the main leader board in benchmarking EEG-analysis algorithms to predict depression status https://lnkd.in/gEaSuk57 . Super proud with Chirath Hettiarachchi as Supervisors at ANU School of Computing, ANU College of Systems & Society, The Australian National University to see our honours student shine!

Congrats Kirby Wraith from The Australian National University with the #1 position at the TDBRAIN Challenge for replicated diagnos...

03 December 2025
Congrats Kirby Wraith from The Australian National University with the #1 position at the TDBRAIN Challenge for replicated diagnostic predicton accuracy for Depression using EEG data only at a 62% balanced accuracy! Many AI and ML studies suggest 'unrealistic' 90+% accuracies, all without proper out-of-sample replications. This was our main driver to release the open-access EEG database TDBRAIN including more then 1200 EEGs and rich phenotype data. Glad to see a first diagnostic replication with a realistic accuracy. For full details see here: https://lnkd.in/eseDiM9p

We regularly post news on Linkedin. Please follow us on Linkedin to get the latest news in your Linkedin feed. You can also follow us on other channels on which we regularly post interesting items.